Kikuchi-Fujimoto Disease (Histiocytic Necrotizing Lymphadenitis)
Kikuchi-Fujimoto Disease (Histiocytic Necrotizing Lymphadenitis)
Kikuchi-Fujimoto Disease (KFD), also known as Histiocytic Necrotizing Lymphadenitis or Kikuchi's Disease, is a rare, benign, and self-limiting condition characterized by regional lymphadenopathy, typically cervical, often accompanied by fever and systemic symptoms. It was first described independently by Kikuchi and Fujimoto in Japan in 1972. Although initially reported in young Asian females, KFD has since been recognized worldwide across various demographics.
Epidemiology
- Age: Typically affects young adults, with a mean age of onset between 20-30 years. Pediatric cases are increasingly recognized.
- Gender: Female predominance, with a female-to-male ratio of approximately 4:1, although this ratio may be lower in some populations.
- Geographic distribution: Originally described in Japan, but now reported worldwide. Higher prevalence in Asian populations.
- Incidence: Exact incidence is unknown due to potential underdiagnosis. In a study from the United States, KFD represented 0.6% of 1,724 lymph node biopsies.
- Seasonal variation: Some studies suggest a higher incidence in spring and summer months.
Etiopathogenesis
The exact cause of Kikuchi-Fujimoto Disease remains unknown. However, several theories have been proposed:
- Infectious trigger:
- Various infectious agents have been implicated, including Epstein-Barr virus (EBV), human herpesvirus 6 (HHV-6), human herpesvirus 8 (HHV-8), parvovirus B19, and Yersinia enterocolitica.
- However, a consistent association with any specific pathogen has not been established.
- Autoimmune mechanism:
- KFD shares clinical and histological features with systemic lupus erythematosus (SLE).
- Some patients develop autoimmune disorders, particularly SLE, before, during, or after KFD diagnosis.
- Elevated levels of interferon-alpha (IFN-α) and increased plasmacytoid dendritic cells in affected lymph nodes suggest a potential role of autoimmunity.
- Genetic susceptibility:
- Certain HLA class II alleles (HLA-DPA1 and HLA-DPB1) have been associated with increased susceptibility to KFD in some populations.
- Apoptotic cell death:
- Histopathological findings suggest that apoptosis plays a crucial role in the pathogenesis of KFD.
- Increased expression of apoptosis-related proteins (e.g., Fas, FasL, perforin) has been observed in affected lymph nodes.
Clinical Features
The clinical presentation of Kikuchi-Fujimoto Disease can vary, but typically includes:
- Lymphadenopathy:
- Most common and often the presenting symptom
- Usually cervical (60-90% of cases), particularly posterior cervical chain
- Can be unilateral or bilateral
- Lymph nodes are typically firm, tender, and mobile
- Other sites: axillary, supraclavicular, mediastinal, and rarely inguinal
- Fever:
- Present in 30-50% of cases
- Usually low-grade, but can be high and prolonged in some cases
- Constitutional symptoms:
- Fatigue
- Night sweats
- Weight loss
- Cutaneous manifestations:
- Occur in 5-30% of patients
- Maculopapular rash, erythema multiforme-like lesions, or urticaria
- Neurological symptoms:
- Rare, but can include aseptic meningitis, encephalitis, or neuritis
- Other symptoms:
- Hepatosplenomegaly (in 5-15% of cases)
- Arthralgia or arthritis
- Myalgia
- Nausea and vomiting
Diagnosis
The diagnosis of Kikuchi-Fujimoto Disease requires a combination of clinical, laboratory, and histopathological findings:
- Clinical evaluation:
- Detailed history and physical examination
- Assessment of lymphadenopathy and associated symptoms
- Laboratory studies:
- Complete blood count (CBC): May show leukopenia or atypical lymphocytes
- Elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)
- Liver function tests: Mild elevation of transaminases in some cases
- Autoantibody screening: To rule out associated autoimmune disorders
- Imaging studies:
- Ultrasonography of affected lymph nodes
- CT or MRI to assess the extent of lymphadenopathy and exclude other causes
- Histopathological examination:
- Excisional lymph node biopsy is the gold standard for diagnosis
- Characteristic features include:
- Paracortical expansion with areas of necrosis
- Karyorrhectic debris with abundant histiocytes (crescentic histiocytes and plasmacytoid monocytes)
- Absence of neutrophils and plasma cells
- Proliferation of immunoblasts (predominantly T-cells)
- Immunohistochemistry:
- CD68+ and myeloperoxidase+ histiocytes
- CD8+ T-cells predominate over CD4+ T-cells
- Absence of CD20+ B-cells
Differential Diagnosis
The differential diagnosis of Kikuchi-Fujimoto Disease is broad and includes:
- Infectious causes:
- Viral lymphadenitis (EBV, CMV, HIV)
- Toxoplasmosis
- Tuberculosis
- Cat-scratch disease
- Autoimmune disorders:
- Systemic lupus erythematosus (SLE)
- Adult-onset Still's disease
- Malignancies:
- Lymphoma (particularly non-Hodgkin lymphoma)
- Metastatic carcinoma
- Other conditions:
- Sarcoidosis
- Kawasaki disease (in pediatric patients)
- Drug-induced lymphadenopathy
Treatment
Kikuchi-Fujimoto Disease is typically self-limiting, and treatment is mainly supportive. Management strategies include:
- Observation and monitoring:
- Most cases resolve spontaneously within 1-4 months
- Regular follow-up to monitor symptom progression and potential complications
- Symptomatic relief:
- Analgesics and antipyretics (e.g., NSAIDs) for pain and fever
- Rest and adequate hydration
- Corticosteroids:
- Reserved for severe or persistent cases
- May be considered in patients with neurological involvement or hepatic dysfunction
- Typical regimen: Prednisone 1 mg/kg/day with gradual tapering
- Hydroxychloroquine:
- May be beneficial in refractory cases or patients with associated autoimmune features
- Intravenous immunoglobulin (IVIG):
- Reported to be effective in some severe or recurrent cases
- Management of underlying conditions:
- Treatment of associated autoimmune disorders, if present
Prognosis
The prognosis of Kikuchi-Fujimoto Disease is generally excellent:
- Self-limiting course in most cases, with resolution within 1-4 months
- Recurrence rate of 3-4% reported in some studies
- Mortality is extremely rare and usually associated with complications
- Long-term follow-up is recommended due to the association with autoimmune disorders, particularly SLE
Complications
Although rare, complications of Kikuchi-Fujimoto Disease can occur:
- Neurological complications:
- Aseptic meningitis
- Encephalitis
- Cerebellar ataxia
- Hemophagocytic lymphohistiocytosis (HLH):
- Rare but potentially life-threatening complication
- Characterized by excessive immune activation and cytokine storm
- Hepatic dysfunction:
- Usually mild and self-limiting
- Severe cases may require corticosteroid treatment
- Development of autoimmune disorders:
- Particularly systemic lupus erythematosus (SLE)
- Can occur before, during, or after KFD diagnosis
- Prolonged or recurrent course:
- May lead to significant morbidity and decreased quality of life
Kikuchi-Fujimoto Disease (Histiocytic Necrotizing Lymphadenitis)
- What is the alternative name for Kikuchi-Fujimoto Disease?
Answer: Histiocytic Necrotizing Lymphadenitis - Who first described Kikuchi-Fujimoto Disease?
Answer: Dr. Masahiro Kikuchi and Dr. Y. Fujimoto, independently - In which year was Kikuchi-Fujimoto Disease first described?
Answer: 1972 - What is the typical age group affected by Kikuchi-Fujimoto Disease?
Answer: Young adults, typically under 40 years old - Is there a gender predilection in Kikuchi-Fujimoto Disease?
Answer: Yes, it's more common in females - Which ethnic group has a higher reported incidence of Kikuchi-Fujimoto Disease?
Answer: Asian populations - What is the most common clinical presentation of Kikuchi-Fujimoto Disease?
Answer: Cervical lymphadenopathy - Is Kikuchi-Fujimoto Disease typically unilateral or bilateral?
Answer: Usually unilateral - What is the typical size range of affected lymph nodes in Kikuchi-Fujimoto Disease?
Answer: 0.5-4 cm - Are the affected lymph nodes in Kikuchi-Fujimoto Disease usually tender?
Answer: Yes, they are often tender - What is the most common systemic symptom associated with Kikuchi-Fujimoto Disease?
Answer: Fever - Can Kikuchi-Fujimoto Disease affect extranodal sites?
Answer: Yes, but it's rare - What is the typical duration of symptoms in Kikuchi-Fujimoto Disease?
Answer: 1-4 months - Is Kikuchi-Fujimoto Disease considered a self-limiting condition?
Answer: Yes, it typically resolves spontaneously - What is the recurrence rate of Kikuchi-Fujimoto Disease?
Answer: Approximately 3-4% - What is the gold standard for diagnosing Kikuchi-Fujimoto Disease?
Answer: Lymph node biopsy - What are the characteristic histological findings in Kikuchi-Fujimoto Disease?
Answer: Paracortical necrosis with karyorrhectic debris and proliferation of histiocytes and plasmacytoid dendritic cells - Is neutrophil infiltration a typical feature of Kikuchi-Fujimoto Disease?
Answer: No, neutrophils are characteristically absent - What autoimmune disease is most commonly associated with Kikuchi-Fujimoto Disease?
Answer: Systemic Lupus Erythematosus (SLE) - Can Kikuchi-Fujimoto Disease mimic lymphoma?
Answer: Yes, it's an important differential diagnosis - What is the typical ESR finding in Kikuchi-Fujimoto Disease?
Answer: Elevated - Is leukopenia a common finding in Kikuchi-Fujimoto Disease?
Answer: Yes - What is the role of antibiotics in treating Kikuchi-Fujimoto Disease?
Answer: They are not effective as it's not a bacterial infection - Are corticosteroids routinely used in treating Kikuchi-Fujimoto Disease?
Answer: No, they're reserved for severe or persistent cases - What is the primary treatment approach for Kikuchi-Fujimoto Disease?
Answer: Supportive care and symptomatic treatment - Can Kikuchi-Fujimoto Disease affect pregnancy?
Answer: Yes, it has been reported during pregnancy - Is there a known infectious cause of Kikuchi-Fujimoto Disease?
Answer: No specific infectious agent has been consistently identified - What is the typical LDH level in Kikuchi-Fujimoto Disease?
Answer: Often elevated - Can Kikuchi-Fujimoto Disease affect the central nervous system?
Answer: Rarely, but CNS involvement has been reporte - What is the mortality rate associated with Kikuchi-Fujimoto Disease?
Answer: Very low, deaths are extremely rare - Can Kikuchi-Fujimoto Disease affect children?
Answer: Yes, but it's less common than in young adults - Is there a specific diagnostic blood test for Kikuchi-Fujimoto Disease?
Answer: No, diagnosis is based on clinical presentation and histopathology
Disclaimer
The notes provided on Pediatime are generated from online resources and AI sources and have been carefully checked for accuracy. However, these notes are not intended to replace standard textbooks. They are designed to serve as a quick review and revision tool for medical students and professionals, and to aid in theory exam preparation. For comprehensive learning, please refer to recommended textbooks and guidelines.
